BioSpace News Archive

Prostate Cancer Therapeutics Market: Hormone Therapy to Dominate Market

Transparency Market Research has published a new report on the prostate cancer therapeutics market for the forecast period of 2019–2027.

April 28, 2021
·
5 min read
Osteoporosis Drugs Market: North America to Dominate Global Market

Transparency Market Research has published a new report titled, ‘Osteoporosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

April 28, 2021
·
5 min read
Inhalation and Nasal Spray Generic Drugs Market: Asthma Indication to be Highly Lucrative Segment

Transparency Market Research has published a new report titled, ‘Inhalation and Nasal Sprays Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

April 28, 2021
·
6 min read
Face Shield Market | Know the Exclusive Trends and Revenues in the Market

The face shield market may reach for the escalator to great growth opportunities across the forecast period of 2019-2029.

April 28, 2021
·
3 min read
Policy

Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA

Protalix BioTherapeutics, Inc. and Chiesi Global Rare Diseases announced that they received a Complete Response Letter from the U.S. Food and Drug Administration regarding the Biologics License Application seeking accelerated approval of pegunigalsidase alfa for the proposed treatment of adult patients with Fabry disease.

April 28, 2021
·
10 min read
DIC Invests in Israeli Biotech Startup Vaxa Technologies

DIC Corporation has completed investment in Vaxa Technologies Ltd., a biotech startup headquartered in Rosh Pina, Israel, as part of a strategic expansion of DIC businesses around health food and other algae-derived products.

April 28, 2021
·
2 min read
Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority

Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development announced that it has submitted a request to the Malta Medicines Authority for a Scientific Opinion on its investigational new drug QIXLEEF for Tetra’s clinical trial programs.

April 28, 2021
·
4 min read
Pharm Country

Amicus Therapeutics Recognized as a Great Place to Work® in EuropeGreat Place to Work® Certification in the United Kingdom, Spain, Italy and Germany

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that it has been recognized by the prestigious Great Place to Work® Institute as among the best places to work in the United Kingdom, Spain, Italy and Germany.

April 28, 2021
·
2 min read
Business

Valeo Pharma’s Redesca and Redesca HP to Be Covered Under the Ontario Public Drug Benefit Program

Valeo Pharma Inc . a Canadian pharmaceutical company, today announced that it has entered into a Product Listing Agreement (“PLA”) with the Executive Officer of the Ontario Public Drug Program

April 28, 2021
·
2 min read
Business

Karyopharm to Report First Quarter 2021 Financial Results on May 3, 2021

-- Conference Call Scheduled for Monday, May 3, 2021, at 8:30 a.m. ET --

April 28, 2021
·
2 min read